Cardium Therapeutics, Inc. (CXM) Posts Q2 Loss of 37c/Share
Tweet Send to a Friend
Cardium Therapeutics, Inc. (AMEX: CXM) reported Q2 EPS of ($0.37) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
